ArticleMedicine2019

Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan.

Chieh-Hua Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.